Unbiased Analysis of Today's Healthcare Issues
An interesting report from the European Observatory on Health Systems and Policies examined the “Use of digital health tools in Europe: before, during and after COVID-19“. Digital health is important not only because the technologies facilitate communication and disease monitoring, but also the technologies facilitate the creation of data that can be used to better…
Cell and gene therapies have the potential to produce dramatic improvements in quality of life and survival for severe and often rare diseases. Currently, however, the cost of these treatments is high and access is sometimes limited. To identify some of these challenges in Europe EURODIS conducted an evaluation of country-specific challenges with respect to…
In his 2018 State of the Union address, President Trump said that “fixing the injustice of high drug prices” will be one of the top priorities of his administration in the coming year. Lower drug prices could directly benefit consumers without insurance or those with high-deductible health plans; commercially insured individuals could hope to see…
In 2008, 2.45 million people were diagnosed with cancer and 1.23 million died because of cancer in the European Union (EU). What is the economic burden of cancer? A paper by Luengo-Fernandez (2013) aims to estimate just this quantity. They find that: Cancer cost the EU €126 billion in 2009…Across the EU, the health-care costs…
One of the most contentious parts of the healthcare debate in the U.S. is whether or not to move towards a more European style of health care. Those in favor cite the equality of the system, the lower cost, and lower administrative cost. Those against rail against the lack of provider choice and the long…